Trial Profile
A Phase 1, Two Part, Open-Label, Single Center, Clinical Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of Parenterally Administered Dutogliptin in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 May 2020
Price :
$35
*
At a glance
- Drugs Dutogliptin (Primary) ; Dutogliptin (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions
- Sponsors RECARDIO
- 18 May 2020 According to a RECARDIO media release, results from this trial were published in the British Journal of Pharmacology.
- 18 May 2020 Results presented in a RECARDIO media release.
- 07 Jan 2020 Results assessing Safety, tolerability, pharmacokinetics and pharmacodynamics of parenterally administered dutogliptin published in the British Journal of Clinical Pharmacology